Circulating CD31+/Annexin V+ EVs were found to be increased in patients with stable CAD and cardiovascular risk factors (e.g. diabetes) suggesting them as an independent risk factor for cardiovascular outcomes in patients with CAD [174]. This evidence concerns the gene ANXA5 and coronary artery disorder.